CCN3 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, although the McCallum’s study argues that the CCN3 secretion is controlled by direct activity of BCR-ABL, they verify the downregulated levels of cellular CCN3 in CML cells.